Cargando…
“Abnormal Analyte Preeclampsia”: Do the second trimester maternal serum analytes help differentiate preeclampsia subtypes?
OBJECTIVE: To determine if serum screen analytes identify preeclamptic patients at risk for small-for-gestational-age newborns, maternal laboratory abnormalities and preterm delivery (<37 weeks gestation). STUDY DESIGN: Using a retrospective cohort of 102 preeclamptic patients, associations betwe...
Autores principales: | CRITCHFIELD, Agatha S, PAULUS, Jessica K, FAREZ, Rahmouna, URATO, Adam C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3760989/ https://www.ncbi.nlm.nih.gov/pubmed/23702620 http://dx.doi.org/10.1038/jp.2013.55 |
Ejemplares similares
-
Gut microbiota dysbiosis in preeclampsia patients in the second and third trimesters
por: Wang, Jing, et al.
Publicado: (2020) -
Maternal Vitamin D Status in the Late Second Trimester and the Risk of Severe Preeclampsia in Southeastern China
por: Zhao, Xin, et al.
Publicado: (2017) -
Evaluation of first trimester maternal serum inhibin-A for preeclampsia screening
por: Moungmaithong, Sakita, et al.
Publicado: (2023) -
Association between risk of preeclampsia and maternal plasma trimethylamine-N-oxide in second trimester and at the time of delivery
por: Huang, Xin, et al.
Publicado: (2020) -
Correlation of Maternal Serum Homocysteine in the First Trimester with the Development of Gestational Hypertension and Preeclampsia
por: Sun, Feng, et al.
Publicado: (2017)